Moderna, Inc. (MRNA)
About Moderna, Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $1.9B
- Net income
- -$2.8B
- Total assets
- $12.3B
- Market cap
- $21.5B
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $21.5B
- Shares outstanding
- 107.9M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 7, 2018
Moderna, Inc. (MRNA) Stock Price
- Reported a net loss of $2.8B in FY2025.
- Trading 19% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Moderna, Inc..
Write a review
News about Moderna, Inc.
News & sentiment via Polygon.io
Moderna, Inc.: frequently asked questions
Is Moderna, Inc. an American company?
Yes — Moderna, Inc. is an American company. Moderna, Inc. is incorporated in Delaware, United States and headquartered in Cambridge, Massachusetts. Its legal-entity record reports no foreign parent — the company is independently American-owned.
Where is Moderna, Inc. incorporated?
Moderna, Inc. is legally incorporated in Delaware, United States, according to its GLEIF legal-entity record.
Who owns Moderna, Inc.?
Moderna, Inc. reports no parent company in its legal-entity record — it is independently owned rather than a subsidiary.
Is Moderna, Inc. traded on a US stock exchange?
Yes — Moderna, Inc. trades under the ticker MRNA on the NASDAQ.
Where is Moderna, Inc. headquartered?
Moderna, Inc. is headquartered in Cambridge, Massachusetts, United States.
Is Moderna, Inc. publicly traded?
Yes — Moderna, Inc. is a publicly traded company. Its stock trades under the ticker symbol MRNA on the NASDAQ.
What does Moderna, Inc. do?
Moderna, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
When was Moderna, Inc. founded?
Moderna, Inc. was founded in 2010.
